Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


7th Assay & Drug Discovery Technologies Conference

24 Oct 2012 - 26 Oct 2012 - Philadelphia, PA, USA



Bookmark and Share


Over the years, the field of assay technologies, laboratory automation, and informatics has taken great leaps in advancement. Present demands from the drug discovery process have propelled a shift in focus from high throughput screening to high content analysis in the assay and drug discovery technology arena. There has also been a push for more physiologically relevant biochemical and cell based assays for compound screening. New avenues for exploration like the applications of epigenetics and the use of stem cell screening and nano screening are also emerging on the forefront of discovery techniques. The economic landscape has also created a sense of urgency for the pharmaceutical industry to further reduce the cost of research and development, leading to discussions of the feasibility of outsourcing screening and analysis. Join us as we will bring together industry leaders from major pharmaceutical companies and cutting-edge biotech companies as well as top researchers from academia and government to present innovative and relevant applications of current assay technologies to continually improve efficacy and meaningful data output and discuss the potential of novel analytical and screening technologies in drug discovery and development.




Further information
Scientific News
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!